Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today reported financial results for the third quarter ended ...

Q3 2025 Earnings Call Transcript November 3, 2025 Krystal Biotech, Inc. beats earnings expectations. Reported EPS is $2.66, ...

Scientists developed a wireless brain implant smaller than a grain of sand that recorded neural activity in mice for 365 days ...

Q3 2025 Earnings Call Transcript November 3, 2025 Karyopharm Therapeutics Inc. misses on earnings expectations. Reported EPS ...

ASX-listed medtech companies have been rolling out their latest quarterly results, showing solid progress across key areas ...

Google Translate has always been a useful app for travelers abroad, but it has also rolled out a few improvements that people ...

Q3 2025 Earnings Call November 3, 2025 4:30 PM ESTCompany ParticipantsRobert DeVitaDavid Hung - Founder, President, CEO ...

Good afternoon, and welcome to Sarepta's Third Quarter 2025 Financial Results Conference Call. As a reminder, today's program is being recorded. At this time, I'll turn the call over to Tam Thornton, ...

Scilex Holding Company ("Scilex" or the "Company") (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing ...

Rapid patient enrollment underscores strong market interest and reinforces commercialization opportunity for fully implanted ...

Gross margin was 85.8% for the third quarter of 2025 compared to 84.1% in the third quarter of 2024. The year-over-year increase was due to higher sales volume and higher Inspire V sales mix, which ...